ImmunoCellular Therapeutics Announces Third Quarter 2013 Financial Results

07-11-2013 Business Wire HealthComments (0)

Pharmaceutical

ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular”) (NYSE MKT: IMUC) today announced financial results for the quarter ended September 30, 2013. For the three months ended September 30, 2013, the Company incurred a net loss of $3.8 million, or $0.07 per basic and diluted share, compared to a net loss of $600,000, or $0.02 per basic and diluted share during the quarter ended September 30, 2012. The net loss in the current quarter reflects a charge of $1.4 million r

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top